P
JAZZ icon

&Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

&Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$742K Buy
3,078
+318
+12% +$69.7K ﹤0.01% 1606
2026
Q1 		$522K Buy
2,760
+127
+5% +$22.2K ﹤0.01% 1670
2025
Q4 		$448K Sell
2,633
-1,944
-42% -$298K ﹤0.01% 1676
2025
Q3 		$603K Sell
4,577
-300
-6% -$36K ﹤0.01% 1345
2025
Q2 		$517K Buy
4,877
+872
+22% +$94.7K ﹤0.01% 1339
2025
Q1 		$493K Buy
4,005
+333
+9% +$43.4K 0.01% 1139
2024
Q4 		$443K Buy
+3,672
New +$433K 0.01% 1128

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

&Partners's JAZZ Position: Q2 2026 in Review

&Partners increased its Jazz Pharmaceuticals (JAZZ) stake by 12% in Q2 2026, buying an estimated $69.7K and bringing the position to 3,078 shares worth $742K. The position accounts for ﹤0.01% of the portfolio, ranked #1606.

&Partners first reported a position in JAZZ in Q4 2024 and has held it in 7 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • &Partners held 3,078 shares of Jazz Pharmaceuticals worth $742K as of Q2 2026.
  • &Partners bought 318 Jazz Pharmaceuticals shares in Q2 2026, an estimated $69.7K.
  • Jazz Pharmaceuticals made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1606 holding.
  • &Partners first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.